Polyhydroxyalkanoate Nanoparticles for Pulmonary Drug Delivery: Interaction with Lung Surfactant
Polyhydroxyalkanoates (PHA) are polyesters produced intracellularly by many bacterial species as energy storage materials, which are used in biomedical applications, including drug delivery systems, due to their biocompatibility and biodegradability. In this study, we evaluated the potential applica...
Main Authors: | Olga Cañadas, Andrea García-García, M. Auxiliadora Prieto, Jesús Pérez-Gil |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/11/6/1482 |
Similar Items
-
Impact of Polymer Nanoparticles on DPPC Monolayer Properties
by: Alexey Bykov, et al.
Published: (2022-04-01) -
Interactions of pulmonary surfactant protein SP-A with monolayers of dipalmitoylphosphatidylcholine and cholesterol: roles of SP-A domains
by: Shou-Hwa Yu, et al.
Published: (1999-05-01) -
Licofelone-DPPC Interactions: Putting Membrane Lipids on the Radar of Drug Development
by: Catarina Pereira-Leite, et al.
Published: (2019-01-01) -
A recipe for a good clinical pulmonary surfactant
by: Jesús Pérez-Gil
Published: (2022-08-01) -
Effect of Silica Microparticles on Interactions in Mono- and Multicomponent Membranes
by: Beata Tim, et al.
Published: (2022-10-01)